nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—CYP1A1—breast cancer	0.112	0.343	CbGaD
Propranolol—CYP2D6—breast cancer	0.0831	0.255	CbGaD
Propranolol—CYP3A4—breast cancer	0.0712	0.219	CbGaD
Propranolol—ABCB1—breast cancer	0.0593	0.182	CbGaD
Propranolol—CYP1A1—Toremifene—breast cancer	0.0391	0.0873	CbGbCtD
Propranolol—CYP1A2—Anastrozole—breast cancer	0.0191	0.0427	CbGbCtD
Propranolol—CYP1A2—Toremifene—breast cancer	0.0175	0.039	CbGbCtD
Propranolol—CYP3A5—Lapatinib—breast cancer	0.0171	0.0382	CbGbCtD
Propranolol—ABCB1—Toremifene—breast cancer	0.0153	0.0341	CbGbCtD
Propranolol—SLC22A2—Vinblastine—breast cancer	0.0143	0.032	CbGbCtD
Propranolol—CYP1A1—Tamoxifen—breast cancer	0.0143	0.0319	CbGbCtD
Propranolol—CYP2C19—Lapatinib—breast cancer	0.0138	0.0308	CbGbCtD
Propranolol—CYP3A4—Exemestane—breast cancer	0.0132	0.0295	CbGbCtD
Propranolol—CYP2D6—Idarubicin—breast cancer	0.0119	0.0266	CbGbCtD
Propranolol—CYP3A7—Tamoxifen—breast cancer	0.0114	0.0255	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0114	0.0255	CbGbCtD
Propranolol—CYP3A4—Letrozole—breast cancer	0.0112	0.0251	CbGbCtD
Propranolol—ABCB1—Lapatinib—breast cancer	0.0112	0.0249	CbGbCtD
Propranolol—CYP3A4—Anastrozole—breast cancer	0.01	0.0223	CbGbCtD
Propranolol—CYP3A4—Toremifene—breast cancer	0.00916	0.0204	CbGbCtD
Propranolol—CYP3A7—Paclitaxel—breast cancer	0.0089	0.0199	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.0089	0.0199	CbGbCtD
Propranolol—CYP3A7—Irinotecan—breast cancer	0.00878	0.0196	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00878	0.0196	CbGbCtD
Propranolol—CYP3A5—Tamoxifen—breast cancer	0.00858	0.0191	CbGbCtD
Propranolol—CYP3A4—Fulvestrant—breast cancer	0.00852	0.019	CbGbCtD
Propranolol—CYP3A4—Thiotepa—breast cancer	0.00759	0.0169	CbGbCtD
Propranolol—CYP3A4—Ixabepilone—breast cancer	0.00694	0.0155	CbGbCtD
Propranolol—CYP2C19—Tamoxifen—breast cancer	0.00692	0.0154	CbGbCtD
Propranolol—CYP3A4—Lapatinib—breast cancer	0.00668	0.0149	CbGbCtD
Propranolol—CYP3A5—Paclitaxel—breast cancer	0.00668	0.0149	CbGbCtD
Propranolol—CYP3A5—Irinotecan—breast cancer	0.00659	0.0147	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00644	0.0144	CbGbCtD
Propranolol—CYP3A7—Docetaxel—breast cancer	0.00644	0.0144	CbGbCtD
Propranolol—CYP1A2—Tamoxifen—breast cancer	0.00639	0.0143	CbGbCtD
Propranolol—ABCB1—Vinorelbine—breast cancer	0.00619	0.0138	CbGbCtD
Propranolol—CYP2D6—Vinorelbine—breast cancer	0.00583	0.013	CbGbCtD
Propranolol—ABCB1—Tamoxifen—breast cancer	0.00559	0.0125	CbGbCtD
Propranolol—ABCB1—Mitoxantrone—breast cancer	0.00545	0.0122	CbGbCtD
Propranolol—CYP2D6—Tamoxifen—breast cancer	0.00526	0.0117	CbGbCtD
Propranolol—CYP3A4—Raloxifene—breast cancer	0.00506	0.0113	CbGbCtD
Propranolol—CYP3A5—Docetaxel—breast cancer	0.00483	0.0108	CbGbCtD
Propranolol—ABCB1—Gemcitabine—breast cancer	0.00481	0.0107	CbGbCtD
Propranolol—CYP1A2—Fluorouracil—breast cancer	0.00471	0.0105	CbGbCtD
Propranolol—ABCB1—Paclitaxel—breast cancer	0.00435	0.0097	CbGbCtD
Propranolol—ABCB1—Irinotecan—breast cancer	0.00429	0.00957	CbGbCtD
Propranolol—ABCB1—Vinblastine—breast cancer	0.00381	0.00851	CbGbCtD
Propranolol—CYP3A4—Vinorelbine—breast cancer	0.00371	0.00827	CbGbCtD
Propranolol—CYP2D6—Vinblastine—breast cancer	0.00359	0.00802	CbGbCtD
Propranolol—CYP3A4—Tamoxifen—breast cancer	0.00335	0.00747	CbGbCtD
Propranolol—CYP3A4—Mitoxantrone—breast cancer	0.00326	0.00728	CbGbCtD
Propranolol—ABCB1—Docetaxel—breast cancer	0.00314	0.00701	CbGbCtD
Propranolol—CYP3A4—Paclitaxel—breast cancer	0.0026	0.00581	CbGbCtD
Propranolol—CYP3A4—Irinotecan—breast cancer	0.00257	0.00573	CbGbCtD
Propranolol—ABCB1—Doxorubicin—breast cancer	0.00234	0.00523	CbGbCtD
Propranolol—CYP3A4—Vinblastine—breast cancer	0.00228	0.0051	CbGbCtD
Propranolol—ABCB1—Methotrexate—breast cancer	0.00227	0.00506	CbGbCtD
Propranolol—CYP2D6—Doxorubicin—breast cancer	0.00221	0.00493	CbGbCtD
Propranolol—CYP3A4—Docetaxel—breast cancer	0.00188	0.0042	CbGbCtD
Propranolol—CYP3A4—Doxorubicin—breast cancer	0.0014	0.00313	CbGbCtD
Propranolol—Carvedilol—HIF1A—breast cancer	0.00039	0.118	CrCbGaD
Propranolol—ADRB3—adipose tissue—breast cancer	0.000282	0.0703	CbGeAlD
Propranolol—ADRB3—female reproductive system—breast cancer	0.000259	0.0647	CbGeAlD
Propranolol—ADRB3—female gonad—breast cancer	0.000236	0.0588	CbGeAlD
Propranolol—Terbinafine—CYP19A1—breast cancer	0.000209	0.0632	CrCbGaD
Propranolol—Terbinafine—PTGS1—breast cancer	0.000168	0.0509	CrCbGaD
Propranolol—CYP3A7—endocrine gland—breast cancer	0.000161	0.0401	CbGeAlD
Propranolol—Carvedilol—VEGFA—breast cancer	0.000157	0.0476	CrCbGaD
Propranolol—ORM1—endometrium—breast cancer	0.000145	0.0362	CbGeAlD
Propranolol—Carteolol—CYP2D6—breast cancer	0.00014	0.0425	CrCbGaD
Propranolol—CYP1A2—nipple—breast cancer	0.000139	0.0346	CbGeAlD
Propranolol—CYP1A1—nipple—breast cancer	0.000137	0.0341	CbGeAlD
Propranolol—ORM1—female reproductive system—breast cancer	0.00012	0.03	CbGeAlD
Propranolol—ADRB1—adipose tissue—breast cancer	0.000115	0.0288	CbGeAlD
Propranolol—Terbinafine—CYP2D6—breast cancer	0.000114	0.0346	CrCbGaD
Propranolol—Ranolazine—CYP2D6—breast cancer	0.000114	0.0346	CrCbGaD
Propranolol—ORM1—bone marrow—breast cancer	0.000114	0.0283	CbGeAlD
Propranolol—HTR1B—female reproductive system—breast cancer	0.000113	0.0281	CbGeAlD
Propranolol—Cinacalcet—CYP2D6—breast cancer	0.00011	0.0333	CrCbGaD
Propranolol—Betaxolol—CYP2D6—breast cancer	0.00011	0.0333	CrCbGaD
Propranolol—Bisoprolol—CYP2D6—breast cancer	0.000106	0.0322	CrCbGaD
Propranolol—ADRB1—female reproductive system—breast cancer	0.000106	0.0264	CbGeAlD
Propranolol—ORM1—endocrine gland—breast cancer	0.000102	0.0254	CbGeAlD
Propranolol—Acebutolol—CYP2D6—breast cancer	0.000101	0.0305	CrCbGaD
Propranolol—Oxprenolol—CYP2D6—breast cancer	9.99e-05	0.0303	CrCbGaD
Propranolol—Ranolazine—CYP3A4—breast cancer	9.8e-05	0.0297	CrCbGaD
Propranolol—Terbinafine—CYP3A4—breast cancer	9.8e-05	0.0297	CrCbGaD
Propranolol—HTR1B—endocrine gland—breast cancer	9.54e-05	0.0238	CbGeAlD
Propranolol—Cinacalcet—CYP3A4—breast cancer	9.44e-05	0.0286	CrCbGaD
Propranolol—CYP1A1—epithelium—breast cancer	9.21e-05	0.023	CbGeAlD
Propranolol—Alprenolol—CYP2D6—breast cancer	9.14e-05	0.0277	CrCbGaD
Propranolol—Bisoprolol—CYP3A4—breast cancer	9.11e-05	0.0276	CrCbGaD
Propranolol—ADRB1—endocrine gland—breast cancer	8.98e-05	0.0224	CbGeAlD
Propranolol—HTR1A—adrenal gland—breast cancer	8.88e-05	0.0221	CbGeAlD
Propranolol—CYP1A1—skin of body—breast cancer	8.76e-05	0.0218	CbGeAlD
Propranolol—Duloxetine—CYP2D6—breast cancer	8.62e-05	0.0261	CrCbGaD
Propranolol—Metoprolol—CYP2D6—breast cancer	8.49e-05	0.0257	CrCbGaD
Propranolol—Carvedilol—PTGS1—breast cancer	8.28e-05	0.0251	CrCbGaD
Propranolol—Pindolol—CYP2D6—breast cancer	7.86e-05	0.0238	CrCbGaD
Propranolol—Atenolol—ABCB1—breast cancer	7.79e-05	0.0236	CrCbGaD
Propranolol—HTR1A—endocrine gland—breast cancer	7.7e-05	0.0192	CbGeAlD
Propranolol—CYP1A1—uterus—breast cancer	7.61e-05	0.019	CbGeAlD
Propranolol—Carvedilol—CYP1A1—breast cancer	7.58e-05	0.023	CrCbGaD
Propranolol—CYP1A1—adipose tissue—breast cancer	7.44e-05	0.0186	CbGeAlD
Propranolol—CYP3A5—adipose tissue—breast cancer	7.28e-05	0.0181	CbGeAlD
Propranolol—CYP2C19—endocrine gland—breast cancer	7.19e-05	0.0179	CbGeAlD
Propranolol—Acebutolol—ABCB1—breast cancer	7.19e-05	0.0218	CrCbGaD
Propranolol—ORM1—lymph node—breast cancer	7.04e-05	0.0175	CbGeAlD
Propranolol—CYP1A1—female reproductive system—breast cancer	6.84e-05	0.0171	CbGeAlD
Propranolol—Body temperature increased—Irinotecan—breast cancer	6.66e-05	0.000489	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Doxorubicin—breast cancer	6.66e-05	0.000489	CcSEcCtD
Propranolol—Bronchitis—Epirubicin—breast cancer	6.65e-05	0.000487	CcSEcCtD
Propranolol—Infestation—Methotrexate—breast cancer	6.59e-05	0.000483	CcSEcCtD
Propranolol—Infestation NOS—Methotrexate—breast cancer	6.59e-05	0.000483	CcSEcCtD
Propranolol—Depression—Methotrexate—breast cancer	6.57e-05	0.000481	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Methotrexate—breast cancer	6.53e-05	0.000479	CcSEcCtD
Propranolol—Vomiting—Vinorelbine—breast cancer	6.5e-05	0.000477	CcSEcCtD
Propranolol—Body temperature increased—Gemcitabine—breast cancer	6.49e-05	0.000476	CcSEcCtD
Propranolol—Neutropenia—Epirubicin—breast cancer	6.46e-05	0.000474	CcSEcCtD
Propranolol—Dizziness—Thiotepa—breast cancer	6.46e-05	0.000473	CcSEcCtD
Propranolol—Rash—Vinorelbine—breast cancer	6.45e-05	0.000473	CcSEcCtD
Propranolol—Dermatitis—Vinorelbine—breast cancer	6.44e-05	0.000472	CcSEcCtD
Propranolol—Urticaria—Fluorouracil—breast cancer	6.41e-05	0.00047	CcSEcCtD
Propranolol—Body temperature increased—Fluorouracil—breast cancer	6.38e-05	0.000468	CcSEcCtD
Propranolol—Propafenone—CYP2D6—breast cancer	6.26e-05	0.019	CrCbGaD
Propranolol—Cough—Docetaxel—breast cancer	6.23e-05	0.000457	CcSEcCtD
Propranolol—CYP1A1—female gonad—breast cancer	6.22e-05	0.0155	CbGeAlD
Propranolol—Insomnia—Paclitaxel—breast cancer	6.22e-05	0.000456	CcSEcCtD
Propranolol—Vertigo—Capecitabine—breast cancer	6.21e-05	0.000455	CcSEcCtD
Propranolol—Hypersensitivity—Irinotecan—breast cancer	6.21e-05	0.000455	CcSEcCtD
Propranolol—Hypersensitivity—Mitoxantrone—breast cancer	6.21e-05	0.000455	CcSEcCtD
Propranolol—Vomiting—Thiotepa—breast cancer	6.21e-05	0.000455	CcSEcCtD
Propranolol—Convulsion—Docetaxel—breast cancer	6.19e-05	0.000454	CcSEcCtD
Propranolol—Paraesthesia—Paclitaxel—breast cancer	6.17e-05	0.000453	CcSEcCtD
Propranolol—Infestation—Epirubicin—breast cancer	6.16e-05	0.000452	CcSEcCtD
Propranolol—Infestation NOS—Epirubicin—breast cancer	6.16e-05	0.000452	CcSEcCtD
Propranolol—Rash—Thiotepa—breast cancer	6.16e-05	0.000451	CcSEcCtD
Propranolol—Bronchitis—Doxorubicin—breast cancer	6.15e-05	0.000451	CcSEcCtD
Propranolol—Dermatitis—Thiotepa—breast cancer	6.15e-05	0.000451	CcSEcCtD
Propranolol—Agranulocytosis—Methotrexate—breast cancer	6.15e-05	0.000451	CcSEcCtD
Propranolol—Dyspnoea—Paclitaxel—breast cancer	6.13e-05	0.000449	CcSEcCtD
Propranolol—Somnolence—Paclitaxel—breast cancer	6.11e-05	0.000448	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Epirubicin—breast cancer	6.11e-05	0.000448	CcSEcCtD
Propranolol—CYP3A5—female gonad—breast cancer	6.09e-05	0.0152	CbGeAlD
Propranolol—Nausea—Vinorelbine—breast cancer	6.07e-05	0.000445	CcSEcCtD
Propranolol—Metoprolol—ABCB1—breast cancer	6.07e-05	0.0184	CrCbGaD
Propranolol—Dyspepsia—Paclitaxel—breast cancer	6.05e-05	0.000444	CcSEcCtD
Propranolol—Asthenia—Irinotecan—breast cancer	6.05e-05	0.000443	CcSEcCtD
Propranolol—Asthenia—Mitoxantrone—breast cancer	6.05e-05	0.000443	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	6.04e-05	0.000443	CcSEcCtD
Propranolol—Cough—Capecitabine—breast cancer	6.03e-05	0.000442	CcSEcCtD
Propranolol—Neutropenia—Doxorubicin—breast cancer	5.98e-05	0.000439	CcSEcCtD
Propranolol—Decreased appetite—Paclitaxel—breast cancer	5.98e-05	0.000438	CcSEcCtD
Propranolol—Hypersensitivity—Fluorouracil—breast cancer	5.95e-05	0.000436	CcSEcCtD
Propranolol—Gastrointestinal disorder—Paclitaxel—breast cancer	5.94e-05	0.000435	CcSEcCtD
Propranolol—Fatigue—Paclitaxel—breast cancer	5.93e-05	0.000435	CcSEcCtD
Propranolol—Asthenia—Gemcitabine—breast cancer	5.89e-05	0.000432	CcSEcCtD
Propranolol—Pain—Paclitaxel—breast cancer	5.88e-05	0.000431	CcSEcCtD
Propranolol—Constipation—Paclitaxel—breast cancer	5.88e-05	0.000431	CcSEcCtD
Propranolol—CYP1A2—endocrine gland—breast cancer	5.87e-05	0.0146	CbGeAlD
Propranolol—Pharyngitis—Methotrexate—breast cancer	5.87e-05	0.00043	CcSEcCtD
Propranolol—ABCB1—embryo—breast cancer	5.86e-05	0.0146	CbGeAlD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	5.85e-05	0.000429	CcSEcCtD
Propranolol—Anaphylactic shock—Docetaxel—breast cancer	5.83e-05	0.000427	CcSEcCtD
Propranolol—Nausea—Thiotepa—breast cancer	5.8e-05	0.000425	CcSEcCtD
Propranolol—Infection—Docetaxel—breast cancer	5.79e-05	0.000425	CcSEcCtD
Propranolol—CYP1A1—endocrine gland—breast cancer	5.79e-05	0.0144	CbGeAlD
Propranolol—Diarrhoea—Irinotecan—breast cancer	5.77e-05	0.000423	CcSEcCtD
Propranolol—Diarrhoea—Mitoxantrone—breast cancer	5.77e-05	0.000423	CcSEcCtD
Propranolol—Agranulocytosis—Epirubicin—breast cancer	5.75e-05	0.000422	CcSEcCtD
Propranolol—Nervous system disorder—Docetaxel—breast cancer	5.72e-05	0.000419	CcSEcCtD
Propranolol—Infestation NOS—Doxorubicin—breast cancer	5.7e-05	0.000418	CcSEcCtD
Propranolol—Infestation—Doxorubicin—breast cancer	5.7e-05	0.000418	CcSEcCtD
Propranolol—Visual impairment—Methotrexate—breast cancer	5.7e-05	0.000418	CcSEcCtD
Propranolol—Skin disorder—Docetaxel—breast cancer	5.66e-05	0.000415	CcSEcCtD
Propranolol—CYP3A5—endocrine gland—breast cancer	5.66e-05	0.0141	CbGeAlD
Propranolol—Stevens-Johnson syndrome—Doxorubicin—breast cancer	5.65e-05	0.000415	CcSEcCtD
Propranolol—Carvedilol—CYP2D6—breast cancer	5.64e-05	0.0171	CrCbGaD
Propranolol—Bradycardia—Epirubicin—breast cancer	5.63e-05	0.000413	CcSEcCtD
Propranolol—Gastrointestinal pain—Paclitaxel—breast cancer	5.62e-05	0.000412	CcSEcCtD
Propranolol—Diarrhoea—Gemcitabine—breast cancer	5.62e-05	0.000412	CcSEcCtD
Propranolol—Infection—Capecitabine—breast cancer	5.61e-05	0.000411	CcSEcCtD
Propranolol—Erythema multiforme—Methotrexate—breast cancer	5.59e-05	0.00041	CcSEcCtD
Propranolol—Dizziness—Irinotecan—breast cancer	5.57e-05	0.000409	CcSEcCtD
Propranolol—Nervous system disorder—Capecitabine—breast cancer	5.53e-05	0.000406	CcSEcCtD
Propranolol—Diarrhoea—Fluorouracil—breast cancer	5.52e-05	0.000405	CcSEcCtD
Propranolol—Pharyngitis—Epirubicin—breast cancer	5.49e-05	0.000403	CcSEcCtD
Propranolol—Cardiac disorder—Methotrexate—breast cancer	5.49e-05	0.000402	CcSEcCtD
Propranolol—Skin disorder—Capecitabine—breast cancer	5.48e-05	0.000402	CcSEcCtD
Propranolol—Urticaria—Paclitaxel—breast cancer	5.46e-05	0.0004	CcSEcCtD
Propranolol—Abdominal pain—Paclitaxel—breast cancer	5.44e-05	0.000399	CcSEcCtD
Propranolol—Body temperature increased—Paclitaxel—breast cancer	5.44e-05	0.000399	CcSEcCtD
Propranolol—Propafenone—CYP3A4—breast cancer	5.37e-05	0.0163	CrCbGaD
Propranolol—Vomiting—Irinotecan—breast cancer	5.36e-05	0.000393	CcSEcCtD
Propranolol—Vomiting—Mitoxantrone—breast cancer	5.36e-05	0.000393	CcSEcCtD
Propranolol—Dizziness—Fluorouracil—breast cancer	5.34e-05	0.000391	CcSEcCtD
Propranolol—Visual impairment—Epirubicin—breast cancer	5.33e-05	0.000391	CcSEcCtD
Propranolol—Agranulocytosis—Doxorubicin—breast cancer	5.32e-05	0.00039	CcSEcCtD
Propranolol—Rash—Mitoxantrone—breast cancer	5.32e-05	0.00039	CcSEcCtD
Propranolol—Rash—Irinotecan—breast cancer	5.32e-05	0.00039	CcSEcCtD
Propranolol—Dermatitis—Irinotecan—breast cancer	5.31e-05	0.000389	CcSEcCtD
Propranolol—Dermatitis—Mitoxantrone—breast cancer	5.31e-05	0.000389	CcSEcCtD
Propranolol—Insomnia—Docetaxel—breast cancer	5.27e-05	0.000386	CcSEcCtD
Propranolol—Paraesthesia—Docetaxel—breast cancer	5.23e-05	0.000384	CcSEcCtD
Propranolol—Erythema multiforme—Epirubicin—breast cancer	5.23e-05	0.000384	CcSEcCtD
Propranolol—Alopecia—Methotrexate—breast cancer	5.22e-05	0.000383	CcSEcCtD
Propranolol—Vomiting—Gemcitabine—breast cancer	5.22e-05	0.000383	CcSEcCtD
Propranolol—Bradycardia—Doxorubicin—breast cancer	5.21e-05	0.000382	CcSEcCtD
Propranolol—Dyspnoea—Docetaxel—breast cancer	5.2e-05	0.000381	CcSEcCtD
Propranolol—Somnolence—Docetaxel—breast cancer	5.18e-05	0.00038	CcSEcCtD
Propranolol—Mental disorder—Methotrexate—breast cancer	5.18e-05	0.00038	CcSEcCtD
Propranolol—Rash—Gemcitabine—breast cancer	5.18e-05	0.00038	CcSEcCtD
Propranolol—Dermatitis—Gemcitabine—breast cancer	5.17e-05	0.000379	CcSEcCtD
Propranolol—Erythema—Methotrexate—breast cancer	5.15e-05	0.000377	CcSEcCtD
Propranolol—Cardiac disorder—Epirubicin—breast cancer	5.13e-05	0.000376	CcSEcCtD
Propranolol—Vomiting—Fluorouracil—breast cancer	5.13e-05	0.000376	CcSEcCtD
Propranolol—Dyspepsia—Docetaxel—breast cancer	5.13e-05	0.000376	CcSEcCtD
Propranolol—Insomnia—Capecitabine—breast cancer	5.1e-05	0.000374	CcSEcCtD
Propranolol—Rash—Fluorouracil—breast cancer	5.09e-05	0.000373	CcSEcCtD
Propranolol—Dermatitis—Fluorouracil—breast cancer	5.09e-05	0.000373	CcSEcCtD
Propranolol—Pharyngitis—Doxorubicin—breast cancer	5.08e-05	0.000373	CcSEcCtD
Propranolol—Paraesthesia—Capecitabine—breast cancer	5.07e-05	0.000371	CcSEcCtD
Propranolol—Decreased appetite—Docetaxel—breast cancer	5.07e-05	0.000371	CcSEcCtD
Propranolol—Hypersensitivity—Paclitaxel—breast cancer	5.07e-05	0.000371	CcSEcCtD
Propranolol—Gastrointestinal disorder—Docetaxel—breast cancer	5.03e-05	0.000369	CcSEcCtD
Propranolol—Dyspnoea—Capecitabine—breast cancer	5.03e-05	0.000369	CcSEcCtD
Propranolol—Fatigue—Docetaxel—breast cancer	5.02e-05	0.000368	CcSEcCtD
Propranolol—CYP3A4—female reproductive system—breast cancer	5.02e-05	0.0125	CbGeAlD
Propranolol—Nausea—Irinotecan—breast cancer	5.01e-05	0.000367	CcSEcCtD
Propranolol—Nausea—Mitoxantrone—breast cancer	5.01e-05	0.000367	CcSEcCtD
Propranolol—Pain—Docetaxel—breast cancer	4.98e-05	0.000365	CcSEcCtD
Propranolol—Constipation—Docetaxel—breast cancer	4.98e-05	0.000365	CcSEcCtD
Propranolol—Dyspepsia—Capecitabine—breast cancer	4.97e-05	0.000364	CcSEcCtD
Propranolol—CYP2D6—female reproductive system—breast cancer	4.94e-05	0.0123	CbGeAlD
Propranolol—Visual impairment—Doxorubicin—breast cancer	4.93e-05	0.000362	CcSEcCtD
Propranolol—Asthenia—Paclitaxel—breast cancer	4.93e-05	0.000362	CcSEcCtD
Propranolol—Decreased appetite—Capecitabine—breast cancer	4.9e-05	0.00036	CcSEcCtD
Propranolol—Alopecia—Epirubicin—breast cancer	4.89e-05	0.000358	CcSEcCtD
Propranolol—Nausea—Gemcitabine—breast cancer	4.88e-05	0.000358	CcSEcCtD
Propranolol—Gastrointestinal disorder—Capecitabine—breast cancer	4.87e-05	0.000357	CcSEcCtD
Propranolol—Fatigue—Capecitabine—breast cancer	4.86e-05	0.000357	CcSEcCtD
Propranolol—Mental disorder—Epirubicin—breast cancer	4.85e-05	0.000355	CcSEcCtD
Propranolol—Erythema multiforme—Doxorubicin—breast cancer	4.84e-05	0.000355	CcSEcCtD
Propranolol—Carvedilol—CYP3A4—breast cancer	4.84e-05	0.0147	CrCbGaD
Propranolol—Pain—Capecitabine—breast cancer	4.82e-05	0.000354	CcSEcCtD
Propranolol—Constipation—Capecitabine—breast cancer	4.82e-05	0.000354	CcSEcCtD
Propranolol—Erythema—Epirubicin—breast cancer	4.82e-05	0.000353	CcSEcCtD
Propranolol—Nausea—Fluorouracil—breast cancer	4.8e-05	0.000352	CcSEcCtD
Propranolol—ABCB1—epithelium—breast cancer	4.78e-05	0.0119	CbGeAlD
Propranolol—Gastrointestinal pain—Docetaxel—breast cancer	4.77e-05	0.000349	CcSEcCtD
Propranolol—Cardiac disorder—Doxorubicin—breast cancer	4.75e-05	0.000348	CcSEcCtD
Propranolol—Diarrhoea—Paclitaxel—breast cancer	4.7e-05	0.000345	CcSEcCtD
Propranolol—Vertigo—Methotrexate—breast cancer	4.62e-05	0.000339	CcSEcCtD
Propranolol—Gastrointestinal pain—Capecitabine—breast cancer	4.61e-05	0.000338	CcSEcCtD
Propranolol—Body temperature increased—Docetaxel—breast cancer	4.61e-05	0.000338	CcSEcCtD
Propranolol—Abdominal pain—Docetaxel—breast cancer	4.61e-05	0.000338	CcSEcCtD
Propranolol—Dizziness—Paclitaxel—breast cancer	4.55e-05	0.000333	CcSEcCtD
Propranolol—Alopecia—Doxorubicin—breast cancer	4.52e-05	0.000332	CcSEcCtD
Propranolol—Atomoxetine—CYP2D6—breast cancer	4.51e-05	0.0137	CrCbGaD
Propranolol—CYP2D6—female gonad—breast cancer	4.49e-05	0.0112	CbGeAlD
Propranolol—Cough—Methotrexate—breast cancer	4.49e-05	0.000329	CcSEcCtD
Propranolol—Mental disorder—Doxorubicin—breast cancer	4.48e-05	0.000329	CcSEcCtD
Propranolol—Urticaria—Capecitabine—breast cancer	4.48e-05	0.000329	CcSEcCtD
Propranolol—Propafenone—ABCB1—breast cancer	4.47e-05	0.0135	CrCbGaD
Propranolol—Body temperature increased—Capecitabine—breast cancer	4.46e-05	0.000327	CcSEcCtD
Propranolol—Abdominal pain—Capecitabine—breast cancer	4.46e-05	0.000327	CcSEcCtD
Propranolol—Convulsion—Methotrexate—breast cancer	4.46e-05	0.000327	CcSEcCtD
Propranolol—Erythema—Doxorubicin—breast cancer	4.46e-05	0.000327	CcSEcCtD
Propranolol—Agitation—Epirubicin—breast cancer	4.43e-05	0.000325	CcSEcCtD
Propranolol—Vomiting—Paclitaxel—breast cancer	4.37e-05	0.000321	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.35e-05	0.000319	CcSEcCtD
Propranolol—Rash—Paclitaxel—breast cancer	4.34e-05	0.000318	CcSEcCtD
Propranolol—Dermatitis—Paclitaxel—breast cancer	4.33e-05	0.000318	CcSEcCtD
Propranolol—Vertigo—Epirubicin—breast cancer	4.33e-05	0.000317	CcSEcCtD
Propranolol—Hypersensitivity—Docetaxel—breast cancer	4.29e-05	0.000315	CcSEcCtD
Propranolol—ABCB1—endometrium—breast cancer	4.29e-05	0.0107	CbGeAlD
Propranolol—CYP3A4—endocrine gland—breast cancer	4.25e-05	0.0106	CbGeAlD
Propranolol—Cough—Epirubicin—breast cancer	4.2e-05	0.000308	CcSEcCtD
Propranolol—Anaphylactic shock—Methotrexate—breast cancer	4.2e-05	0.000308	CcSEcCtD
Propranolol—Asthenia—Docetaxel—breast cancer	4.18e-05	0.000307	CcSEcCtD
Propranolol—CYP2D6—endocrine gland—breast cancer	4.18e-05	0.0104	CbGeAlD
Propranolol—Convulsion—Epirubicin—breast cancer	4.17e-05	0.000306	CcSEcCtD
Propranolol—Infection—Methotrexate—breast cancer	4.17e-05	0.000306	CcSEcCtD
Propranolol—Hypersensitivity—Capecitabine—breast cancer	4.16e-05	0.000305	CcSEcCtD
Propranolol—Nervous system disorder—Methotrexate—breast cancer	4.12e-05	0.000302	CcSEcCtD
Propranolol—Agitation—Doxorubicin—breast cancer	4.1e-05	0.0003	CcSEcCtD
Propranolol—Nausea—Paclitaxel—breast cancer	4.08e-05	0.000299	CcSEcCtD
Propranolol—Skin disorder—Methotrexate—breast cancer	4.08e-05	0.000299	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.07e-05	0.000299	CcSEcCtD
Propranolol—Asthenia—Capecitabine—breast cancer	4.05e-05	0.000297	CcSEcCtD
Propranolol—Carvedilol—ABCB1—breast cancer	4.03e-05	0.0122	CrCbGaD
Propranolol—Vertigo—Doxorubicin—breast cancer	4e-05	0.000294	CcSEcCtD
Propranolol—CYP1A1—lymph node—breast cancer	4e-05	0.00998	CbGeAlD
Propranolol—Diarrhoea—Docetaxel—breast cancer	3.99e-05	0.000292	CcSEcCtD
Propranolol—ABCB1—uterus—breast cancer	3.95e-05	0.00985	CbGeAlD
Propranolol—Anaphylactic shock—Epirubicin—breast cancer	3.93e-05	0.000288	CcSEcCtD
Propranolol—Infection—Epirubicin—breast cancer	3.91e-05	0.000286	CcSEcCtD
Propranolol—Cough—Doxorubicin—breast cancer	3.89e-05	0.000285	CcSEcCtD
Propranolol—ABCB1—pituitary gland—breast cancer	3.88e-05	0.00968	CbGeAlD
Propranolol—Atomoxetine—CYP3A4—breast cancer	3.87e-05	0.0117	CrCbGaD
Propranolol—ABCB1—adipose tissue—breast cancer	3.87e-05	0.00964	CbGeAlD
Propranolol—Convulsion—Doxorubicin—breast cancer	3.86e-05	0.000283	CcSEcCtD
Propranolol—Diarrhoea—Capecitabine—breast cancer	3.86e-05	0.000283	CcSEcCtD
Propranolol—Nervous system disorder—Epirubicin—breast cancer	3.85e-05	0.000283	CcSEcCtD
Propranolol—Dizziness—Docetaxel—breast cancer	3.85e-05	0.000283	CcSEcCtD
Propranolol—Skin disorder—Epirubicin—breast cancer	3.82e-05	0.00028	CcSEcCtD
Propranolol—Insomnia—Methotrexate—breast cancer	3.8e-05	0.000279	CcSEcCtD
Propranolol—Paraesthesia—Methotrexate—breast cancer	3.77e-05	0.000277	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.77e-05	0.000276	CcSEcCtD
Propranolol—Dyspnoea—Methotrexate—breast cancer	3.74e-05	0.000275	CcSEcCtD
Propranolol—Somnolence—Methotrexate—breast cancer	3.73e-05	0.000274	CcSEcCtD
Propranolol—Dizziness—Capecitabine—breast cancer	3.73e-05	0.000274	CcSEcCtD
Propranolol—Vomiting—Docetaxel—breast cancer	3.71e-05	0.000272	CcSEcCtD
Propranolol—Dyspepsia—Methotrexate—breast cancer	3.7e-05	0.000271	CcSEcCtD
Propranolol—Rash—Docetaxel—breast cancer	3.67e-05	0.000269	CcSEcCtD
Propranolol—Dermatitis—Docetaxel—breast cancer	3.67e-05	0.000269	CcSEcCtD
Propranolol—Decreased appetite—Methotrexate—breast cancer	3.65e-05	0.000268	CcSEcCtD
Propranolol—Anaphylactic shock—Doxorubicin—breast cancer	3.64e-05	0.000267	CcSEcCtD
Propranolol—Gastrointestinal disorder—Methotrexate—breast cancer	3.63e-05	0.000266	CcSEcCtD
Propranolol—Fatigue—Methotrexate—breast cancer	3.62e-05	0.000266	CcSEcCtD
Propranolol—Infection—Doxorubicin—breast cancer	3.61e-05	0.000265	CcSEcCtD
Propranolol—Pain—Methotrexate—breast cancer	3.59e-05	0.000263	CcSEcCtD
Propranolol—Vomiting—Capecitabine—breast cancer	3.59e-05	0.000263	CcSEcCtD
Propranolol—Nervous system disorder—Doxorubicin—breast cancer	3.57e-05	0.000262	CcSEcCtD
Propranolol—Rash—Capecitabine—breast cancer	3.56e-05	0.000261	CcSEcCtD
Propranolol—Insomnia—Epirubicin—breast cancer	3.56e-05	0.000261	CcSEcCtD
Propranolol—Dermatitis—Capecitabine—breast cancer	3.55e-05	0.000261	CcSEcCtD
Propranolol—ABCB1—female reproductive system—breast cancer	3.55e-05	0.00886	CbGeAlD
Propranolol—Skin disorder—Doxorubicin—breast cancer	3.53e-05	0.000259	CcSEcCtD
Propranolol—Paraesthesia—Epirubicin—breast cancer	3.53e-05	0.000259	CcSEcCtD
Propranolol—Dyspnoea—Epirubicin—breast cancer	3.5e-05	0.000257	CcSEcCtD
Propranolol—Somnolence—Epirubicin—breast cancer	3.49e-05	0.000256	CcSEcCtD
Propranolol—ABCB1—adrenal gland—breast cancer	3.47e-05	0.00864	CbGeAlD
Propranolol—Nausea—Docetaxel—breast cancer	3.46e-05	0.000254	CcSEcCtD
Propranolol—Dyspepsia—Epirubicin—breast cancer	3.46e-05	0.000254	CcSEcCtD
Propranolol—Gastrointestinal pain—Methotrexate—breast cancer	3.43e-05	0.000252	CcSEcCtD
Propranolol—Decreased appetite—Epirubicin—breast cancer	3.42e-05	0.000251	CcSEcCtD
Propranolol—Gastrointestinal disorder—Epirubicin—breast cancer	3.39e-05	0.000249	CcSEcCtD
Propranolol—Fatigue—Epirubicin—breast cancer	3.39e-05	0.000248	CcSEcCtD
Propranolol—Constipation—Epirubicin—breast cancer	3.36e-05	0.000246	CcSEcCtD
Propranolol—Pain—Epirubicin—breast cancer	3.36e-05	0.000246	CcSEcCtD
Propranolol—ABCB1—bone marrow—breast cancer	3.35e-05	0.00836	CbGeAlD
Propranolol—Nausea—Capecitabine—breast cancer	3.35e-05	0.000246	CcSEcCtD
Propranolol—Urticaria—Methotrexate—breast cancer	3.34e-05	0.000245	CcSEcCtD
Propranolol—Body temperature increased—Methotrexate—breast cancer	3.32e-05	0.000243	CcSEcCtD
Propranolol—Abdominal pain—Methotrexate—breast cancer	3.32e-05	0.000243	CcSEcCtD
Propranolol—Insomnia—Doxorubicin—breast cancer	3.29e-05	0.000241	CcSEcCtD
Propranolol—Paraesthesia—Doxorubicin—breast cancer	3.27e-05	0.000239	CcSEcCtD
Propranolol—Dyspnoea—Doxorubicin—breast cancer	3.24e-05	0.000238	CcSEcCtD
Propranolol—Somnolence—Doxorubicin—breast cancer	3.23e-05	0.000237	CcSEcCtD
Propranolol—ABCB1—female gonad—breast cancer	3.23e-05	0.00806	CbGeAlD
Propranolol—Gastrointestinal pain—Epirubicin—breast cancer	3.21e-05	0.000236	CcSEcCtD
Propranolol—Dyspepsia—Doxorubicin—breast cancer	3.2e-05	0.000235	CcSEcCtD
Propranolol—Decreased appetite—Doxorubicin—breast cancer	3.16e-05	0.000232	CcSEcCtD
Propranolol—Gastrointestinal disorder—Doxorubicin—breast cancer	3.14e-05	0.00023	CcSEcCtD
Propranolol—Fatigue—Doxorubicin—breast cancer	3.14e-05	0.00023	CcSEcCtD
Propranolol—Urticaria—Epirubicin—breast cancer	3.12e-05	0.000229	CcSEcCtD
Propranolol—Constipation—Doxorubicin—breast cancer	3.11e-05	0.000228	CcSEcCtD
Propranolol—Pain—Doxorubicin—breast cancer	3.11e-05	0.000228	CcSEcCtD
Propranolol—Abdominal pain—Epirubicin—breast cancer	3.11e-05	0.000228	CcSEcCtD
Propranolol—Body temperature increased—Epirubicin—breast cancer	3.11e-05	0.000228	CcSEcCtD
Propranolol—Hypersensitivity—Methotrexate—breast cancer	3.09e-05	0.000227	CcSEcCtD
Propranolol—Asthenia—Methotrexate—breast cancer	3.01e-05	0.000221	CcSEcCtD
Propranolol—ABCB1—endocrine gland—breast cancer	3.01e-05	0.0075	CbGeAlD
Propranolol—Gastrointestinal pain—Doxorubicin—breast cancer	2.97e-05	0.000218	CcSEcCtD
Propranolol—Hypersensitivity—Epirubicin—breast cancer	2.9e-05	0.000212	CcSEcCtD
Propranolol—Urticaria—Doxorubicin—breast cancer	2.89e-05	0.000212	CcSEcCtD
Propranolol—Abdominal pain—Doxorubicin—breast cancer	2.88e-05	0.000211	CcSEcCtD
Propranolol—Body temperature increased—Doxorubicin—breast cancer	2.88e-05	0.000211	CcSEcCtD
Propranolol—Diarrhoea—Methotrexate—breast cancer	2.87e-05	0.000211	CcSEcCtD
Propranolol—Asthenia—Epirubicin—breast cancer	2.82e-05	0.000207	CcSEcCtD
Propranolol—Dizziness—Methotrexate—breast cancer	2.78e-05	0.000204	CcSEcCtD
Propranolol—Diarrhoea—Epirubicin—breast cancer	2.69e-05	0.000197	CcSEcCtD
Propranolol—Hypersensitivity—Doxorubicin—breast cancer	2.68e-05	0.000196	CcSEcCtD
Propranolol—Vomiting—Methotrexate—breast cancer	2.67e-05	0.000196	CcSEcCtD
Propranolol—Rash—Methotrexate—breast cancer	2.65e-05	0.000194	CcSEcCtD
Propranolol—Dermatitis—Methotrexate—breast cancer	2.65e-05	0.000194	CcSEcCtD
Propranolol—Asthenia—Doxorubicin—breast cancer	2.61e-05	0.000191	CcSEcCtD
Propranolol—Dizziness—Epirubicin—breast cancer	2.6e-05	0.000191	CcSEcCtD
Propranolol—Vomiting—Epirubicin—breast cancer	2.5e-05	0.000183	CcSEcCtD
Propranolol—Nausea—Methotrexate—breast cancer	2.49e-05	0.000183	CcSEcCtD
Propranolol—Diarrhoea—Doxorubicin—breast cancer	2.49e-05	0.000182	CcSEcCtD
Propranolol—Rash—Epirubicin—breast cancer	2.48e-05	0.000182	CcSEcCtD
Propranolol—Dermatitis—Epirubicin—breast cancer	2.48e-05	0.000182	CcSEcCtD
Propranolol—Dizziness—Doxorubicin—breast cancer	2.41e-05	0.000176	CcSEcCtD
Propranolol—Nausea—Epirubicin—breast cancer	2.33e-05	0.000171	CcSEcCtD
Propranolol—Vomiting—Doxorubicin—breast cancer	2.31e-05	0.00017	CcSEcCtD
Propranolol—Rash—Doxorubicin—breast cancer	2.29e-05	0.000168	CcSEcCtD
Propranolol—Dermatitis—Doxorubicin—breast cancer	2.29e-05	0.000168	CcSEcCtD
Propranolol—Nausea—Doxorubicin—breast cancer	2.16e-05	0.000158	CcSEcCtD
Propranolol—ABCB1—lymph node—breast cancer	2.08e-05	0.00518	CbGeAlD
Propranolol—CYP2D6—Metabolism—GSTM1—breast cancer	2.18e-06	2.63e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.18e-06	2.63e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MDM2—breast cancer	2.18e-06	2.63e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ERCC2—breast cancer	2.18e-06	2.62e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PIK3CA—breast cancer	2.18e-06	2.62e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—STK11—breast cancer	2.17e-06	2.62e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP19A1—breast cancer	2.17e-06	2.62e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—RAF1—breast cancer	2.17e-06	2.62e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—RELA—breast cancer	2.16e-06	2.6e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CG—breast cancer	2.15e-06	2.59e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ERBB2—breast cancer	2.15e-06	2.59e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	2.14e-06	2.58e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SRC—breast cancer	2.13e-06	2.57e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MDM2—breast cancer	2.13e-06	2.57e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—RAF1—breast cancer	2.12e-06	2.56e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP17A1—breast cancer	2.12e-06	2.56e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CB—breast cancer	2.12e-06	2.55e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MTOR—breast cancer	2.12e-06	2.55e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—RELA—breast cancer	2.11e-06	2.55e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TP53—breast cancer	2.11e-06	2.54e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ERBB2—breast cancer	2.1e-06	2.53e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTGS1—breast cancer	2.1e-06	2.53e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ENO1—breast cancer	2.1e-06	2.53e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—MTHFR—breast cancer	2.1e-06	2.53e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	2.09e-06	2.52e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GPX1—breast cancer	2.09e-06	2.52e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PTEN—breast cancer	2.09e-06	2.52e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PTEN—breast cancer	2.08e-06	2.51e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MDM2—breast cancer	2.08e-06	2.51e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VEGFA—breast cancer	2.08e-06	2.5e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—RAF1—breast cancer	2.08e-06	2.5e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MTOR—breast cancer	2.07e-06	2.5e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CB—breast cancer	2.07e-06	2.5e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP1A1—breast cancer	2.07e-06	2.49e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—RELA—breast cancer	2.07e-06	2.49e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2D6—breast cancer	2.06e-06	2.48e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—STAT3—breast cancer	2.06e-06	2.48e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ERBB2—breast cancer	2.05e-06	2.48e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ERCC2—breast cancer	2.05e-06	2.47e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—MTHFR—breast cancer	2.05e-06	2.47e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.04e-06	2.46e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CXCL8—breast cancer	2.04e-06	2.45e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MTOR—breast cancer	2.03e-06	2.44e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CB—breast cancer	2.03e-06	2.44e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—HRAS—breast cancer	2.02e-06	2.44e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—COMT—breast cancer	2.02e-06	2.44e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NCOA2—breast cancer	2.02e-06	2.44e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—HRAS—breast cancer	2.01e-06	2.43e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTP1—breast cancer	2.01e-06	2.42e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CD—breast cancer	2e-06	2.41e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CXCL8—breast cancer	1.99e-06	2.4e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CDKN1B—breast cancer	1.99e-06	2.4e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—HMOX1—breast cancer	1.98e-06	2.39e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ITPR1—breast cancer	1.98e-06	2.39e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—HRAS—breast cancer	1.98e-06	2.39e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ALB—breast cancer	1.98e-06	2.38e-05	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—AKT1—breast cancer	1.97e-06	2.37e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MAPK3—breast cancer	1.96e-06	2.37e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—FASN—breast cancer	1.96e-06	2.36e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—BCHE—breast cancer	1.95e-06	2.35e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CASP3—breast cancer	1.95e-06	2.35e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CXCL8—breast cancer	1.95e-06	2.35e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL2—breast cancer	1.95e-06	2.35e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CDKN1B—breast cancer	1.94e-06	2.35e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL6—breast cancer	1.94e-06	2.33e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—HRAS—breast cancer	1.93e-06	2.33e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CAV1—breast cancer	1.93e-06	2.33e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—MTHFR—breast cancer	1.93e-06	2.32e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL6—breast cancer	1.93e-06	2.32e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SLC5A5—breast cancer	1.93e-06	2.32e-05	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—AKT1—breast cancer	1.92e-06	2.32e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MYC—breast cancer	1.91e-06	2.3e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CASP3—breast cancer	1.91e-06	2.3e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TGFB1—breast cancer	1.91e-06	2.3e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ABCB1—breast cancer	1.9e-06	2.3e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL2—breast cancer	1.9e-06	2.29e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CDKN1B—breast cancer	1.9e-06	2.29e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCND1—breast cancer	1.9e-06	2.29e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL6—breast cancer	1.89e-06	2.28e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—JUN—breast cancer	1.89e-06	2.28e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CD—breast cancer	1.89e-06	2.28e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—NOS3—breast cancer	1.89e-06	2.28e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CAV1—breast cancer	1.89e-06	2.28e-05	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—AKT1—breast cancer	1.88e-06	2.27e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CTNNB1—breast cancer	1.88e-06	2.26e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—TYMS—breast cancer	1.87e-06	2.25e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EGFR—breast cancer	1.87e-06	2.25e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ALB—breast cancer	1.87e-06	2.25e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CASP3—breast cancer	1.86e-06	2.25e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL2—breast cancer	1.86e-06	2.24e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NQO1—breast cancer	1.86e-06	2.24e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SLC2A1—breast cancer	1.86e-06	2.24e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCND1—breast cancer	1.86e-06	2.24e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL6—breast cancer	1.85e-06	2.23e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—JUN—breast cancer	1.85e-06	2.23e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NCOR1—breast cancer	1.85e-06	2.23e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTM1—breast cancer	1.85e-06	2.23e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.85e-06	2.23e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.85e-06	2.23e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MMP9—breast cancer	1.84e-06	2.22e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CTNNB1—breast cancer	1.84e-06	2.22e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CDKN1A—breast cancer	1.83e-06	2.21e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PTEN—breast cancer	1.83e-06	2.21e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCND1—breast cancer	1.81e-06	2.19e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—JUN—breast cancer	1.81e-06	2.18e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MMP9—breast cancer	1.8e-06	2.17e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CTNNB1—breast cancer	1.8e-06	2.17e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CDKN1A—breast cancer	1.79e-06	2.16e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MAPK8—breast cancer	1.79e-06	2.16e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PTEN—breast cancer	1.79e-06	2.16e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—NOS3—breast cancer	1.79e-06	2.15e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—AKT1—breast cancer	1.79e-06	2.15e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP1B1—breast cancer	1.78e-06	2.15e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CAV1—breast cancer	1.78e-06	2.14e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—AKT1—breast cancer	1.78e-06	2.14e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GPX1—breast cancer	1.77e-06	2.13e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—KRAS—breast cancer	1.77e-06	2.13e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MMP9—breast cancer	1.76e-06	2.12e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CG—breast cancer	1.76e-06	2.12e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CDKN1A—breast cancer	1.76e-06	2.12e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP1A1—breast cancer	1.75e-06	2.11e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MAPK8—breast cancer	1.75e-06	2.11e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PTEN—breast cancer	1.75e-06	2.11e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.75e-06	2.11e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—AKT1—breast cancer	1.75e-06	2.11e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CB—breast cancer	1.75e-06	2.1e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ERCC2—breast cancer	1.74e-06	2.1e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTGS2—breast cancer	1.73e-06	2.09e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CG—breast cancer	1.72e-06	2.07e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MAPK8—breast cancer	1.71e-06	2.07e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—AKT1—breast cancer	1.71e-06	2.06e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NCOA1—breast cancer	1.7e-06	2.05e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SRC—breast cancer	1.7e-06	2.05e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—STK11—breast cancer	1.68e-06	2.02e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP19A1—breast cancer	1.68e-06	2.02e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SRC—breast cancer	1.66e-06	2e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VEGFA—breast cancer	1.65e-06	1.99e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CB—breast cancer	1.65e-06	1.99e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—STAT3—breast cancer	1.64e-06	1.97e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTGS2—breast cancer	1.63e-06	1.97e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—MTHFR—breast cancer	1.63e-06	1.97e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SRC—breast cancer	1.62e-06	1.96e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PIK3CA—breast cancer	1.62e-06	1.96e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CG—breast cancer	1.62e-06	1.95e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VEGFA—breast cancer	1.62e-06	1.95e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—STAT3—breast cancer	1.6e-06	1.93e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VEGFA—breast cancer	1.58e-06	1.91e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TP53—breast cancer	1.57e-06	1.89e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—STAT3—breast cancer	1.57e-06	1.89e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MAPK3—breast cancer	1.56e-06	1.89e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—COMT—breast cancer	1.56e-06	1.88e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTP1—breast cancer	1.55e-06	1.87e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CD—breast cancer	1.55e-06	1.87e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HMOX1—breast cancer	1.53e-06	1.85e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MAPK3—breast cancer	1.53e-06	1.84e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ALB—breast cancer	1.53e-06	1.84e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ITPR1—breast cancer	1.53e-06	1.84e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MYC—breast cancer	1.52e-06	1.83e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TGFB1—breast cancer	1.52e-06	1.83e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CD—breast cancer	1.51e-06	1.82e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTEN—breast cancer	1.51e-06	1.82e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CAV1—breast cancer	1.51e-06	1.82e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—HRAS—breast cancer	1.5e-06	1.81e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MAPK3—breast cancer	1.5e-06	1.8e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ALB—breast cancer	1.49e-06	1.8e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MYC—breast cancer	1.49e-06	1.79e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EGFR—breast cancer	1.49e-06	1.79e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TGFB1—breast cancer	1.48e-06	1.79e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PIK3CA—breast cancer	1.47e-06	1.77e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PIK3CA—breast cancer	1.47e-06	1.77e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ABCB1—breast cancer	1.47e-06	1.77e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—NOS3—breast cancer	1.46e-06	1.76e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EGFR—breast cancer	1.46e-06	1.76e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MYC—breast cancer	1.46e-06	1.75e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.45e-06	1.75e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—TYMS—breast cancer	1.44e-06	1.74e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.44e-06	1.74e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL6—breast cancer	1.44e-06	1.73e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—NOS3—breast cancer	1.43e-06	1.72e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTM1—breast cancer	1.43e-06	1.72e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.43e-06	1.72e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NCOR1—breast cancer	1.43e-06	1.72e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTEN—breast cancer	1.43e-06	1.72e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CD—breast cancer	1.42e-06	1.72e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EGFR—breast cancer	1.42e-06	1.72e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—KRAS—breast cancer	1.41e-06	1.69e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ALB—breast cancer	1.41e-06	1.69e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—KRAS—breast cancer	1.38e-06	1.66e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CG—breast cancer	1.37e-06	1.65e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GPX1—breast cancer	1.37e-06	1.65e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP1A1—breast cancer	1.35e-06	1.63e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CB—breast cancer	1.35e-06	1.63e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—NOS3—breast cancer	1.34e-06	1.62e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—KRAS—breast cancer	1.34e-06	1.62e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ERCC2—breast cancer	1.34e-06	1.62e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTGS2—breast cancer	1.34e-06	1.61e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—AKT1—breast cancer	1.32e-06	1.6e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CB—breast cancer	1.32e-06	1.59e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTGS2—breast cancer	1.31e-06	1.57e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CA—breast cancer	1.29e-06	1.56e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CA—breast cancer	1.26e-06	1.52e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—MTHFR—breast cancer	1.26e-06	1.52e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TP53—breast cancer	1.25e-06	1.51e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CB—breast cancer	1.24e-06	1.5e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.24e-06	1.49e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTGS2—breast cancer	1.23e-06	1.48e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TP53—breast cancer	1.22e-06	1.47e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CD—breast cancer	1.21e-06	1.45e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—AKT1—breast cancer	1.2e-06	1.45e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—AKT1—breast cancer	1.2e-06	1.45e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TP53—breast cancer	1.2e-06	1.44e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HRAS—breast cancer	1.19e-06	1.44e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ALB—breast cancer	1.19e-06	1.44e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HRAS—breast cancer	1.17e-06	1.41e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTEN—breast cancer	1.17e-06	1.41e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CAV1—breast cancer	1.16e-06	1.4e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6—breast cancer	1.14e-06	1.38e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HRAS—breast cancer	1.14e-06	1.38e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NOS3—breast cancer	1.14e-06	1.37e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTEN—breast cancer	1.14e-06	1.37e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6—breast cancer	1.12e-06	1.35e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6—breast cancer	1.09e-06	1.32e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTEN—breast cancer	1.07e-06	1.29e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CA—breast cancer	1.06e-06	1.28e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CG—breast cancer	1.06e-06	1.28e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AKT1—breast cancer	1.06e-06	1.27e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CB—breast cancer	1.05e-06	1.27e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTGS2—breast cancer	1.04e-06	1.26e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AKT1—breast cancer	1.03e-06	1.24e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AKT1—breast cancer	1.01e-06	1.22e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CA—breast cancer	1.01e-06	1.21e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CD—breast cancer	9.31e-07	1.12e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALB—breast cancer	9.19e-07	1.11e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTEN—breast cancer	9.09e-07	1.1e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NOS3—breast cancer	8.79e-07	1.06e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—AKT1—breast cancer	8.69e-07	1.05e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CA—breast cancer	8.23e-07	9.92e-06	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AKT1—breast cancer	8.21e-07	9.9e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CB—breast cancer	8.12e-07	9.78e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTGS2—breast cancer	8.04e-07	9.7e-06	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CA—breast cancer	8.03e-07	9.68e-06	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CA—breast cancer	7.57e-07	9.12e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTEN—breast cancer	7.01e-07	8.46e-06	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AKT1—breast cancer	6.72e-07	8.1e-06	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AKT1—breast cancer	6.56e-07	7.91e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CA—breast cancer	6.41e-07	7.73e-06	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AKT1—breast cancer	6.18e-07	7.45e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AKT1—breast cancer	5.24e-07	6.31e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CA—breast cancer	4.95e-07	5.96e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AKT1—breast cancer	4.04e-07	4.87e-06	CbGpPWpGaD
